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Nicotinamide mononucleotide adenylyltransferase
promotes hypoxic survival by activating the
mitochondrial unfolded protein response
XR Mao1,5, DM Kaufman1,2,3 and CM Crowder*,1,3,4

Gain-of-function mutations in the mouse nicotinamide mononucleotide adenylyltransferase type 1 (Nmnat1) produce two
remarkable phenotypes: protection against traumatic axonal degeneration and reduced hypoxic brain injury. Despite intensive
efforts, the mechanism of Nmnat1 cytoprotection remains elusive. To develop a new model to define this mechanism, we
heterologously expressed a mouse Nmnat1 non-nuclear-localized gain-of-function mutant gene (m-nonN-Nmnat1) in the nematode
Caenorhabditis elegans and show that it provides protection from both hypoxia-induced animal death and taxol-induced axonal
pathology. Additionally, we find that m-nonN-Nmnat1 significantly lengthens C. elegans lifespan. Using the hypoxia-protective
phenotype in C. elegans, we performed a candidate screen for genetic suppressors of m-nonN-Nmnat1 cytoprotection. Loss of
function in two genes, haf-1 and dve-1, encoding mitochondrial unfolded protein response (mitoUPR) factors were identified as
suppressors. M-nonN-Nmnat1 induced a transcriptional reporter of the mitoUPR gene hsp-6 and provided protection from the
mitochondrial proteostasis toxin ethidium bromide. M-nonN-Nmnat1 was also protective against axonal degeneration in C. elegans
induced by the chemotherapy drug taxol. Taxol markedly reduced basal expression of a mitoUPR reporter; the expression was
restored by m-nonN-Nmnat1. Taken together, these data implicate the mitoUPR as a mechanism whereby Nmnat1 protects from
hypoxic and axonal injury.
Cell Death and Disease (2016) 7, e2113; doi:10.1038/cddis.2016.5; published online 25 February 2016

About 25 years ago, Lunn et al.1 reported a remarkable mouse
strain (later named wlds) where Wallerian axonal degeneration
after traumatic nerve injury was markedly reduced. The
responsible genetic lesion in the wlds strain was found to be a
translocation and triplication that produced a mutant fusion
protein consisting of a segment of an E4-ubiquitin ligase-like
protein and full-length Nmnat1, a primarily nuclear-localized
nicotinamide adenine dinucleotide (NAD) biosynthetic
enzyme.2–4 Subsequently, overexpression of Nmnat1 or a nonnuclear-localized mutant form of Nmnat1 (nonN-Nmnat1) was
shown to be sufficient to prevent axonal degeneration in mice.5
The mechanism whereby Nmnat1 is axonal protective has
remained elusive, although substantial evidence points to a
mitochondrial site of action.6–8 Recently, a transgenic mouse with
the expression of nonN-Nmnat1 was found to have reduced brain
injury in a model of neonatal hypoxic/ischemic stroke.9 Although
the reduced stroke volume might be secondary to a reduced
axonal degeneration, this result suggests the hypothesis that
nonN-Nmnat1 may have broader cytoprotective properties.

Caenorhabditis elegans has become an increasingly
important model for the study of both hypoxic and axonal
injury.10–16 In this regard, the strengths of the model lie in its
genetic tractability, fully defined anatomy and cellular identity,
and the ability to directly observe cell pathology in live animals.
Screens in C. elegans for genes that control hypoxic sensitivity
have implicated multiple distinct pathways as determinants of
hypoxic death.16–19 In particular, genetic perturbations that
improve cellular proteostasis are generally hypoxia
protective.16–21 These findings argue that hypoxia perturbs
protein folding and that this perturbation contributes to cell
death; indeed, substantial evidence in C. elegans and in other
models indicates that hypoxia/ischemia disrupts protein
folding homeostasis.16,17,19,22,23
In this work, we set out to answer two outstanding questions
about Nmnat1. First, is hypoxia protection a general feature of
Nmnat1 expression or is it peculiar to the mouse transgenic
model previously tested? Second, what is the mechanism
whereby Nmnat1 protects from hypoxia? For the first question,
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Figure 1 m-nonN-Nmnat1 protects primary mouse hippocampal neurons from hypoxic injury. (a) Hypoxic survival of primary mouse hippocampal neurons infected with
lentivirus carrying m-nonN-Nmnat1 or control luciferase. Values are mean ± S.E.M.; Po0.01 by unpaired T-test of four trials. (b) Representative fluorescent photomicrographs of
hypoxia-exposed hippocampal neurons with and without m-nonN-Nmat1 infection. Neurons were visualized with Tuj1 antibody. Scale bar, 10 μm

we expressed the mouse non-nuclear-localized-Nmnat1
(m-nonN-Nmnat1) in two distinct settings, primary mouse
hippocampal neurons and in C. elegans, and asked whether in
these contexts m-nonN-Nmnat1 was hypoxia protective.
Additionally, we overexpressed the C. elegans homologs of
Nmnat1 to determine if other isoforms of Nmnat1 were hypoxia
protective. For the second question, we used the C. elegans
model to test a variety of candidate pathways for their role in
Nmnat1 hypoxia protection.
Results
Mouse nonN-Nmnat1 protects mouse primary hippocampal neuron cultures from hypoxic injury. We first determined whether mouse nonN-Nmnat1 directly protects
neurons from hypoxic injury as our primary interest is
neuronal hypoxic injury and as the previous study showed
Nmnat1 hypoxic protection in a transgenic mouse model
where anti-inflammatory effects or genetic background
contributions cannot be ruled out.9 Using a lentiviral expression system,24 we expressed m-nonN-Nmnat1 in primary
mouse hippocampal neuron cultures essentially devoid of
other cell types and found that m-nonN-Nmnat1 indeed
provides strong hypoxic protection to neurons (Figure 1).
Mouse nonN-Nmnat1 protects C. elegans from hypoxic
injury. Having demonstrated definitively that m-nonNNmnat1 protected mouse neurons from hypoxia, we wanted
to know if this phenotype extended across phyla and
therefore is likely a general property of Nmnat1. Towards
this end, we expressed m-nonN-Nmnat1 heterologously in
the nematode C. elegans (Table 1). As in mouse, m-nonNNmnat1 expression in C. elegans was strongly protective
against hypoxic injury. Strains with ubiquitous expression in
all C. elegans cells (ub-m-nonN-Nmnat1) were hypoxia
resistant with even a single copy insertion conferring
significant hypoxic protection (Figure 2a). Given the primarily
neuronal phenotype in mouse, we asked whether m-nonNNmnat1 expression in neurons alone (neuro-m-nonNNmnat1) is sufficient to protect the organism from hypoxia
Cell Death and Disease

and found that neuronal expression did indeed provide strong
protection (Figure 2b). We examined the relative level of
expression of the various transgenes, in particular to
determine why one of six neuro-m-nonN-Nmnat1 strains
had only a low, nonstatistically significant level of protection.
The level of protection correlated for neuronal transgenes
with the m-nonN-Nmnat1 transcript levels consistent with its
gain-of-function activity (Supplementary Figure S1). We next
asked whether the m-nonN-Nmnat1 transgene was functioning like the native C. elegans Nmnat1 and found that ub-mnonN-Nmnat1 could rescue the sterility phenotype of a
loss-of-function mutant of nmat-2, one of the two C. elegans
Nmnat1 homologs (Figure 2c).25 Similarly, ubiquitous
overexpression of nmat-2 and the other C. elegans Nmnat1
homolog nmat-1 both provided significant hypoxic protection
(Figure 2d). Thus, hypoxia protection is a conserved
phenotype of both worm and mouse Nmnat1 gain-of-function.
M-nonN-Nmnat1 does not affect global oxygen
consumption in C. elegans. Given that Nmnat1 is a
biosynthetic enzyme for NAD, a general mechanism of
Nmnat1 hypoxia protection that we considered was that the
m-nonN-Nmnat1 expression reduces oxygen consumption
and thereby reduces the duration of cellular hypoxia and
severity of injury. However, oxygen consumption was similar
to wild type in both m-nonN-Nmnat1 and nmat-2 overexpression animals (Supplementary Figure S2). Thus, the
observed Nmnat1 hypoxia protection is not because of a
simple oxygen conservation mechanism.
Mitochondrial unfolded protein response genes are
required for m-nonN-Nmnat1 hypoxia resistance. We
tested a variety of mutant genes that might plausibly have a
phenotypic interaction with m-nonN-Nmnat1. Most genes that
were tested had no effect on the hypoxia-protective phenotype (Supplementary Figure S3). However, we found that
loss-of-function mutations in the gene haf-1, which encodes a
mitochondrial outer membrane ABC transporter previously
shown to function as an activator of the mitochondrial
unfolded protein response (mitoUPR),26 significantly
suppressed the hypoxia resistance of both ub-m-nonN-
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Table 1 Summary of strains used in this manuscript

Strain

Parental strain Injected plasmids

gcIs29
gcIs30 IV
gcIs31
gcIs32
gcIs33
gcIs34
gcIs35
gcIs36
gcIs37
gcIs38
gcIs39
gcIs40
gcIs41
gcSi1
gcSi3

N2
N2
N2
N2
N2
N2
N2
N2
N2
N2
N2
N2
N2
EG4322
EG6699

gcSi6 II
gcSi7 IV
gcSi6 II;gcSi7 IV
gcEx145

EG6699
EG6700
N2

Cell type expression Method of integration Coinjection marker

Prpl-28::nmat-2::mCherry
Prab3::mCherry::m-nonN-Nmnat1
Prab3::mCherry::m-nonN-Nmnat1
Prab3::mCherry::m-nonN-Nmnat1
Prab3::mCherry::m-nonN-Nmnat1
Prab3::mCherry::m-nonN-Nmnat1
Prab3::mCherry::m-nonN-Nmnat1
Prab3::mCherry::m-nonN-Nmnat1
Prpl-28::nmat-2::mCherry
Prab3::mCherry::m-nonN-Nmnat1
Prab3::mCherry::m-nonN-Nmnat1
Prpl-28::mCherry::m-nonN-Nmnat1
Prab3::m-nonN-Nmnat1::mCherry
Prpl-28::mCherry::m-nonN-Nmnat1
Prpl-28::nonN-Nmnat1::ERAV2A::nonNNmnat1
Prpl-28::4x-m-nonN-Nmnat1
Prpl-28::3x-m-nonN-Nmnat1
7x-m-nonN-Nmnat1
Prpl-28::nmat-1::mCherry

Nmnat1 and neuro-m-nonN-Nmnat1 transgenes (Figures 3a
and b). The genes dve-1 and atfs-1 also function in the
C. elegans mitoUPR, encoding transcription factors that
promote the expression of the mitochondrial-specific chaperones HSP-6 and HSP-60.26-29 Similar to haf-1(lf) mutants,
dve-1 double-stranded RNA-mediated interference (RNAi)
suppressed the m-nonN-Nmnat1 hypoxia-resistant phenotype (Figure 3c). Interestingly, neither loss-of-function mutations nor RNAi knockdown of atfs-1, a gene believed to be
required for mitoUPR induction under most conditions,
suppressed m-nonN-Nmnat1-mediated hypoxia protection
(Figures 3b and c), demonstrating that m-nonN-Nmnat1 is
activating the mitoUPR in a non-atfs-1-dependent manner.
Several mitochondrial-resident proteases are thought to
function upstream of the peptide transporter HAF-1.27,29
Mutations in these genes greatly compromised worm development and rendered data from the double mutations difficult
to interpret. Nevertheless, in cases where the double mutant
animals were healthy enough for hypoxia testing, none of
these mutations suppressed m-nonN-Nmnat1 hypoxia protection (Supplementary Figure S4a). Thus, the suppression
of the hypoxia-resistant phenotype of m-nonN-Nmnat1 is not
a general property of mitoUPR mutants but is relatively
specific to haf-1 and dve-1. Mutations in ABC transporters for
other organelles such as haf-2 and haf-3 did not suppress
m-nonN-Nmnat1 protection against hypoxia (Supplementary
Figure S4b). Additionally, the suppression by the haf-1 is
specific to Nmnat1 hypoxia resistance in that haf-1(lf) did not
suppress the hypoxic protection produced by a previously
identified hypoxia-resistant allele of the arginyl tRNA synthetase gene – rars-1(gc47) (Figure 3d).17
M-nonN-Nmnat1 worms are long lived. While generally
characterizing the m-nonN-Nmnat1 strains, we found that the
strongly expressing ub-m-nonN-Nmnat1 strain gcIs40 had
two additional phenotypes, reduced fertility and long lifespan
(Supplementary Table S1). We asked whether these Nmnat1
phenotypes were regulated by the same pathways as hypoxic

Ubiquitous
Pan-neuronal
Pan-neuronal
Pan-neuronal
Pan-neuronal
Pan-neuronal
Pan-neuronal
Pan-neuronal
Ubiquitous
Pan-neuronal
Pan-neuronal
Ubiquitous
Pan-neuronal
Ubiquitous
Ubiquitous

UV irradiation
UV irradiation
UV irradiation
UV irradiation
UV irradiation
UV irradiation
UV irradiation
UV irradiation
UV irradiation
UV irradiation
UV irradiation
UV irradiation
UV irradiation
MosSCI
MosSCI

pPHGFP
pPHGFP
pPHGFP
pPHGFP
pPHGFP
pPHGFP
pPHGFP
pPHGFP
pPHGFP
pPHGFP
pPHGFP
pPHGFP
None
unc-119(+)
unc-119(+)

Ubiquitous
Ubiquitous
Ubiquitous
Ubiquitous

MosSCI
MosSCI
MosSCI
Not integrated

unc-119(+)
unc-119(+)
unc-119(+)
pPHGFP

injury. Both haf-1 mutants strongly suppressed the infertility
phenotype of ub-m-nonN-Nmnat1 (Figure 3e and
Supplementary Table S2). However, surprisingly, haf-1
(tm843) did not suppress lifespan extension (Figure 3f). It is
important to point out that infertility was not causally related to
the hypoxia resistance phenotype of m-nonN-Nmnat1 in that
gcSi1, a single copy insertion allele of ub-m-nonN-Nmnat1, is
hypoxia resistant but has normal fertility (Figures 2a and c),
and several of the hypoxia-resistant neuro-m-nonN-Nmnat1
strains have normal fertility (Figures 2b and Supplementary
Table S1). The lack of concordance of the suppression of the
lifespan extension and infertility phenotypes in the haf-1(lf);
gcIs40 mutants argues that the underlying mechanisms of
hypoxia resistance and lifespan extension by Nmnat1 are
also distinct.
M-nonN-Nmnat1 protects from mitochondrial proteostasis stress. The suppression phenotypes by haf-1 and dve-1
loss-of-function suggests that m-nonN-Nmnat1 may ameliorate mitochondrial proteostasis stress. To test this hypothesis,
we measured the sensitivity of m-nonN-Nmnat1 to ethidium
bromide (EtBr), which produces mitochondrial protein folding
stress.30 Both neuronal and ubiquitous m-nonN-Nmnat1
strains were highly protective against the toxic effects of EtBr
(Figure 4a). Consistent with amelioration of mitochondrial
folding stress rather than other effects of EtBr on mitochondria such as suppressing transcription, neuro-m-nonNNmnat1 significantly reduced the induction by EtBr of the
mitoUPR transcriptional reporter, Phsp-6::GFP(zcIs13)
(Figure 4b).30 Surprisingly, in the absence of EtBr, both
neuro- and ub-m-nonN-Nmnat1 mildly but significantly
increased the basal level of activation of Phsp-6::GFP, and
neuro-m-nonN-Nmnat1 increased Phsp-60::GFP (Figures 4c
and d). The results suggest that the protective effect of
m-nonN-Nmnat1 may be hormetic in nature, by producing a
low level of mitochondrial proteostasis stress that induces a
mitoUPR-dependent protective response. Consistent with
this hypothesis, basal mitoUPR induction by m-nonN-Nmnat1
Cell Death and Disease
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Figure 2 m-nonN-Nmnat1 protects worms from hypoxia. (a) Hypoxic survival of ubiquitous-expressing ub-m-nonN-Nmnat1 strains. High copy – gcIs40 and single copy –
gcSi1 integrants of the Prpl-28::mCherry::m-nonN-Nmnat1 transgene were tested. (***Po0.0001, **Po0.01, NS, not significant – unpaired T-test, mean ± S.E.M. shown,
n = 15 trials for N2(wild type) and gcIs40, n = 6 for gcSi1). Inset: gcIs40 worms (top – DIC; bottom – mCherry filter). (b) Hypoxic survival of pan-neuronal-expressing neuro-mnonN-Nmnat1 strains (Prab3::mCherry::m-nonN-Nmnat1) (trials n = 5–20). Inset: gcIs30 worms (top – DIC; bottom – mCherry filter; scale bars for (a) and (b) = 100 μm). (c) The
infertility of nmat-2(tm2905) could be rescued by ubiquitous C. elegans nmat-1 overexpression (gcIs37) and m-nonN-Nmnat1 expression (gcSi1) (each data point represents the
total brood from one animal). (d) Hypoxic survival of C. elegans nmat-1 and nmat-2 overexpression. gcEx145 contains an extrachromosomal nmat-1 array [Prpl-28::nmat-1::
mCherry]; gcIs29 and gcIs37 contain integrated nmat-2 arrays (Prpl-28::nmat-2::mCherry) (trials: n = 12, 7, 12 and 3 for N2, gcIs29, gcIs37 and gcEx154, respectively)

was significantly suppressed by haf-1(lf) (Figure 4e). Moreover, expression of m-nonN-Nmnat1 in mouse primary
hippocampal neurons could induce the expression of
mitochondrial chaperone hspa9 (closest hsp-6 homolog in
mouse); however, no induction of hspd1 was observed
(closest hsp-60 homolog) (Supplementary Figure S5). An
enzymatic activity compromised version of m-nonN-Nmnat1
(H24A)24 had not effect on the expression of hspd1,
demonstrating that enzymatic activity of nonN-Nmnat1 is
required for induction in mouse neurons.
Taxol-induced axonal degeneration ameliorated by
m-nonN-Nmnat1. Finally, we asked whether m-nonNNmnat1 protected against axonal degeneration in C. elegans,
the original phenotype of the wlds mouse. Worm axon
degeneration has been reported in spectrin unc-70 mutants
and in a model of necrosis-induced neuron degeneration,25,31
Cell Death and Disease

and overexpression of worm nmat-2 was shown to be
protective against degeneration of mechanosensory
neurons.25 To examine the role m-nonN-Nmnat1 in axon
degeneration, we used taxol, a chemotherapeutic agent,
previously shown to induce axonal degeneration in cancer
patients and in experimental models.32–34 Worms hatched
from taxol-containing plates had significant growth retardation that could be rescued by ub-m-nonN-Nmnat1
(Figure 5a). To observe axonal degeneration directly,
GFP-labeled mechanosensory neurons were examined after
taxol treatment. In elderly animals, mechanosensory axonal
pathology manifesting as axonal beading and gaps, particularly in the PLM neurons in the tail of the animals, was seen
(Figure 5b) and was significantly increased in taxol-treated
animals (Figure 5c). The taxol-induced axonal degeneration
was significantly reduced by the neuro-m-nonN-Nmnat1
transgene gcIs35 (Figure 5c); the low expressing
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Figure 3 Mitochondrial UPR components are required for m-nonN-Nmnat1 phenotypes. (a and b) Loss-of-function mutations of haf-1 but not atfs-1 suppressed the hypoxia
resistance of Ub-Nmnat1(gcIs40[ub-m-nonN-Nmnat1]) (a) and Neuro-Nmnat1(gcIs30[neuro-m-nonN-Nmnat1] (b) (mean ± S.E.M., unpaired T-test, n = 5–10 trials). (c) RNAi
against dve-1 but not atfs-1 suppressed Ub-Nmnat1(gcIs40[Ub-m-nonN-Nmnat1]) hypoxia resistance. Hypoxic treatment was for 18 h (mean ± S.E.M., unpaired T-test, n = 3
trials). (d) Loss of function of haf-1 did not suppress rars-1(gc47) hypoxia resistance; hypoxic treatment was for 30 h (mean ± S.E.M., unpaired T-test, n = 3 trials). (e) Mutation of
haf-1 rescued the low fertility of Ub-Nmnat1[gcIs40(Ub-m-nonN-Nmnat1]) (n = 14–49, unpaired T-test, N2 versus Ub-Nmnat1 – Po0.0001; N2 versus Neuro-Nmnat1(gcIs30
[Neuro-m-nonN-Nmnat1] – P = 0.13. (f) Worm lifespan was significantly extended by Ub-Nmnat1(gcIs40[ub-m-nonN-Nmnat1] (Po0.0001, N2 versus gcIs40, log-rank test); the
lifespan extension was not significantly suppressed by haf-1(tm843)

gcIs35 transgene was used because it did not extend
lifespan, thereby avoiding a potential confounding factor
(Supplementary Figure S6 and Supplementary Table S2).
Despite initial developmental growth retardation, taxol did not
alter adult lifespan in wild-type animals (Supplementary
Figure S6 and Supplementary Table S2). However, taxol
was lethally toxic to elderly haf-1 but not atfs-1 loss-offunction animals (Figure 5d). These data suggest the
hypotheses that taxol produces mitochondrial folding stress
or that it affects the haf-1-dependent induction of the
mitoUPR in response to mitochondrial proteostatic stress.
Consistent with the latter hypothesis, taxol dose
dependently reduced the basal expression of the Phsp-6::
GFP mitoUPR reporter and this reduction of the expression of
the mitoUPR reporter was blocked by neuronal m-nonNNmnat1 (Figures 5e and f). The analogous ER unfolded
protein response reporter Phsp-4::GFP35 was unaffected by
taxol, indicating relative specificity for the mitoUPR
(Figure 5g).

Discussion
Nmnat1 has been found to protect from axonal degeneration
secondary to a variety of insults.36–39 Most recently, a
transgenic mouse strain expressing the same non-nuclearlocalized Nmnat1 protein used in this study was found to have
a reduced stroke volume following a hypoxic ischemic insult.9
Unlike previous work, the Verghese et al.9 study suggests that
nonN-Nmnat1 protects neuronal cell bodies from acute injury,
not just axons from delayed degeneration. Our results in both
mouse primary neurons and in C. elegans definitively confirm
the hypoxia-protective activity of non-nuclear-localized
Nmnat1. Our data also show that hypoxia protection is not
peculiar to m-nonN-Nmnat1 but rather is a general feature of
Nmnats since overexpressions of two C. elegans Nmnat
homologs also improve hypoxic survival. Additionally, our work
uncovered a novel nicotinamide mononucleotide adenylyltransferase (Nmnat) stress resistant phenotype – prolonged
lifespan. Our data show that m-nonN-Nmnat1 activates the
mitoUPR. Given that the mitoUPR has been implicated in
Cell Death and Disease
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Figure 4 m-nonN-Nmnat1 protects from mitochondrial folding stress and activates the mitoUPR. (a) m-nonN-Nmnat1 protected worms from EtBR-induced developmental
arrest. Eggs were laid on plates with or without EtBr (40 μg/ml) and percent adults was scored 4 days later (mean ± S.E.M., unpaired T-test; n = 4 trials). (b) The induction of the
mitoUPR reporter Phsp-6::GFP (zcIs13) by EtBr was significantly reduced by Neuro-Nmnat1(gcIs41[Neuro-m-nonN-Nmnat1]) (mean ± S.E.M., unpaired T-test; n = 28–50
animals per condition); note gcIs41 heterozygotes were used because of difficulty constructing zcIs13;gcIs41 homozygotes. (c and d) Under basal conditions, both Ub-Nmnat1
(gcSi6;gcSi7[7X-Ub-m-nonN-Nmnat1] and Neuro-Nmnat1(gcIs41[Neuro-m-nonN-Nmat1]) activate mitoUPR reporter zcIs13[Phsp-6::GFP]; Neuro-Nmnat1(gcIs41[Neuro-mnonN-Nmat1]) also activates zcIs9[Phsp-60::GFP]. (e) haf-1(tm843) suppressed Neuro-Nmnat1(gcIs41[neuro-m-nonN-Nmnat1])-induced mitoUPR (for (b–e) mean ± S.E.M.,
unpaired T-test; three trials with at least 15 worms imaged for each genotype/condition)

lifespan extension in C. elegans and other animals,40 it is not
particularly surprising that m-nonN-Nmnat1 extends lifespan
in C. elegans. Further, the lifespan extension phenotype
shows that nonN-Nmnat1 is not only protective against the
acute high level stress of hypoxia and traumatic nerve injury
but also against the indolent stress of aging.
Despite considerable effort, the mechanism whereby
nonN-Nmnat1 protects from axonal degeneration, much less
the mechanism of any of its more recently defined phenotypes,
has not been defined. However, mitochondria have been
repeatedly implicated as having a role. The mitochondrially
localized mammalian isoform Nmnat3 has been shown to
Cell Death and Disease

phenocopy the axonal degeneration-protective activity of the
Nmnat1 wlds mutant, whereas simple overexpression of
the nuclear-localized Nmnat1 or the golgi-localized Nmnat2
does not protect from axonal degeneration.8,41 The
axonal-protective phenotype correlates with nonN-Nmnat1
expression in the mitochondria matrix and mitochondrial ATP
content has been found to be higher in Nmnat3 and wlds mice
compared to wild-type mice.8 Nmnat3 heterologous expression in Drosophila was also protective against axotomyinduced axonal degeneration, and as in mammalian cells,
Nmnat3 localizes to fly mitochondria.6,42 Knockdown of
endogenous Drosophila nicotinamide mononucleotide

Nmnat promotes hypoxic survival
XR Mao et al

7

adenylyltransferase (dNmnat) in fly results in a rapid loss of
axonal mitochondria, suggesting that dNmnat is required for
mitochondrial health.43 Expression of the wlds protein in fly

results in an increase in mitochondrial calcium buffering
capacity resulting in improved axonal mitochondrial motility.42
Whether improved mitochondrial calcium buffering capacity,

Figure 5 m-nonN-Nmnat1 reduces axonal degeneration induced by taxol. (a) Taxol-mediated C. elegans developmental arrest is rescued by Ub-Nmnat1(gcIs40[ub-m-nonNNmnat1]) (mean ± S.E.M., unpaired T-test, three trials). Eggs were laid on taxol plates and four days later the number of adults was scored. (b) Worm mechanosensory neurons
and axons labeled by zdIs5[mec-4::GFP] (scale bar: 100 μm; scale bar in inset: 10 μm). Representative images from the tail region comparing DMSO buffer versus taxol. Note
fragmented (arrow) and beaded (arrowhead) axons in the taxol condition. (c) Taxol-induced axon degeneration was rescued by Neuro-Nmnat1[gcIs35(neuro-m-nonN-Nmnat1])
(Fisher's exact test, 141–494 axons were scored in five independent trials and pooled together). (d) haf-1(tm843) reduced survival of NeuroNmnat1 animals (gcIs35[neuro-mnonN-Nmnat1]) in the presence of chronic taxol but atfs-1(tm4919) did not. Eggs were laid on taxol (3 μM) plates and at 15 days after adulthood, surviving worms were scored
(Fisher's exact test; data were pooled from four independent trials, n = 239–314). (e) Taxol acutely reduced basal mitoUPR reporter zcIs13[Phsp-6::GFP] activity). Inset: worms
under DIC (top) and GFP filter (bottom, scale bar: 100 μm). (f) Heterozygous Neuro-Nmnat1(gcIs41[Neuro-m-nonN-Nmnat1]) preserved mitoUPR reporter activity following taxol
(3 μm) treatment (mean ± S.E.M., unpaired T-test; three independent trials). (g) Taxol did not alter the expression of the ER-UPR reporter activity zcIs4 [Phsp-4::GFP]
(mean ± S.E.M., unpaired T-test; three independent trials)
Cell Death and Disease
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improved mitochondrial proteostasis or a combination of the
two is responsible for Nmnat-mediated stress protection is
unclear. However, we recently reported that hypoxia disrupts
mitochondrial proteostasis and that induction of the mitoUPR
by genetic or pharmacological agents was hypoxia protective
in C. elegans.44 Thus, we favor improved mitochondrial
proteostasis by Nmnat as a primary mediator of hypoxic
survival.
The enzymatic product of Nmnat1, NAD, has been shown to
be axonal-protective5 and to activate the mitoUPR to maintain
mitochondrial proteostasis.45 Further NAD and its precursors
have been found to extend lifespan in C. elegans and multiple
other models.46 Even though overall NAD levels have been
found to be unchanged in nonN-Nmnat1 transgenic mice,24
the enzymatic activity of Nmnat1 is required for its axonalprotective phenotype in mouse and for its hypoxia-protective
phenotype in mouse primary neuron cultures (Supplementary
Figure S5). Mammalian mitochondrial NAD has to be
synthesized in situ by the mitochondrial-specific isoform
Nmnat3;47 perhaps, nonN-Nmnat1 similarly increases mitochondrial NAD levels without affecting overall cellular NAD.
Therefore, our working hypothesis based on these data is that
m-nonN-Nmnat1 maintains mitochondrial NAD levels and
thereby supports mitoUPR function and mitochondrial proteostasis in injured neurons and presumably other cell types to
prevent degeneration and cell death.
Materials and Methods
Strains. C. elegans strains were obtained from the Caenorhabditis Genetics
Center and Japan National BioResource Project and outcrossed three times before
testing. Mutations were confirmed after outcrossing by PCR. All strains were
maintained at 20 °C on nematode growth media agar seeded with OP50 bacteria as
described previously.48 Information for all alleles used is available at www.
wormbase.org, and all mutations were consistent with the published information at
Wormbase. New transgenic strains are listed in Table 1. Double and triple mutant
strains were generated by standard genetic methods,49 and genotypes were
confirmed by phenotype and/or PCR. RNAi experiments were performed as
described previously.18

treatment, worms from these three plates were scored after a 24-h recovery as alive
or dead, and the values from the three plates were pooled as a single trial. Hypoxic
incubation was for 20 h, unless otherwise stated. Numbers of trials are listed in the
individual figure legends.
Fertility tests. L4 worms (14–20 for each genotype) were placed in plates
individually. The worms were transferred to new plates and eggs were counted daily
until no eggs were laid for two consecutive days. Worms burrowing, bagging or
desiccated were censored from analysis.
Lifespan analysis. Lifespan assays were conducted at 20 °C as described
previously.53 After the L4 molting, animals were transferred to plates containing
100 μM 5-fluoro-2′-deoxyuridine (FUDR; Sigma). We used the L4 molt as t = 0 for
lifespan analysis. Strains were grown at 20 °C for at least five generations before
lifespan determination. Exploded, bagged and desiccated worms were censored.
EtBr and taxol developmental assay. EtBr (40 μg/ml) or taxol (3 μM)
were added to plates 24 h before synchronization. Eggs (30–50/plate, three plates/
genotype/trial) were allowed to hatch on EtBr or taxol plates. The adult animals
were counted 4 days after hatching and divided by total eggs to obtain percent of
adults.
O2 consumption. Oxygen consumption assays were performed as reported
previously.16 At least 3000 young adults were used for each test for each genotype
and the experiments were repeated at least three times.
GFP reporter assays. Worms were mounted on 2% agarose pads and
immobilized using 10 μM levamisole in M9. All images were taken using a Zeiss
Axioskop 2 microscope (Carl Zeiss Microscopy, Jena, Germany) with the x10
objective and a Retiga EXi Fast1394 digital camera (QImaging, Surrey, BC,
Canada). At least 15 animals were used for each trial, with at least three trials for
each genotype/treatment. Fluorescent intensities were measured and analyzed with
ImageJ software (NIH, Bethesda, MD, USA) as described previously.17
Taxol and axon degeneration. Paclitaxel/taxol was purchased from Sigma
(T7402) and dissolved in dimethyl sulfoxide (DMSO; Sigma D2650) to make a
10 mM stock solution and stored at − 80 °C. The stock solution was diluted
immediately before use into DMSO to make 0.6 mM intermediate solution, 50 μl of
which was added to NGM plates (10 ml) the night before use to make final 3 μM
taxol assay plates. Control plates contained 50 μl DMSO. The 0.3 and 1 μm plates
were made similarly. Worm populations were synchronized on these plates and
100 μM mitotic inhibitor FUDR (F0503; Sigma) was added into plates once worms
grew into young adults. When the food became scarce, worms were picked onto
new plates with the same conditions. All surviving day 15 adults (L4 = day 0) were
picked to examine axon phenotypes under a compound microscope
(Zeiss Axioskop2 plus, Zeiss North America, Thornwood, NY, USA). Pictures of
all PLM posterior processes were taken by using a x63 objective and Photoshop
software (Adobe Systems, San Jose, CA, USA) was used for further image
processing such as rotating and adding pseudocolor. An axon was scored as
pathological when clear gaps, truncation and beading were present. The images
were scored blinded to condition. Only the posterior processes of PLM neurons
were found to have reproducible axon degeneration. Sporadic degenerations at the
anterior of PLM and in the ALM neurons was rarely observed.

Transgenic animals. nmat-1 and nmat-2 cDNA was amplified from wild-type
N2 and confirmed by sequencing. The rpl-28 promoter (1.4 kb) was subcloned from
the Andy Fire Vector Kit (pPD129.57; Addgene, Cambridge, MA, USA). An
expression construct with the rab-3 promoter was a gift from Mike Nonet
(Washington University School of Medicine, St Louis, MO, USA).50 Mouse nonNNmnat1 cDNA was a gift from Jeffery Milbrandt (Washington University School of
Medicine) and was tagged with mCherry and 6X-His.24 Prpl-28::mCherry::m-nonNNmnat1, Prpl-28::nmat-1::mCherry, Prpl-28::nmat-2::mCherry and Prab3::m-nonNNmnat1::mCherry were injected into N2 gonads along with the coinjection marker
pPHGFP (except gcIs41, which was without coinjection marker).51 Transgenic
animals were selected by the expression of fluorescent markers. To make integrated
lines, 30–40 young adult worms carrying transgenes were UV irradiated as
described previously.51 At least 100 F1s with expression from the transgene were
cloned and lines where 100% of animals stably expressed the transgene were kept
and outcrossed at least 10 times.
Single copy chromosomal insertions were produced as described previously.52
Single copy (gcSi1), two tandem copy (gcSi3) and four tandem copy (gcSi6) of
Prpl-28::m-nonN-Nmnat1 was inserted into ttTi5605 II site by the MosSCI method,
whereas three tandem copies (gcSi7) was inserted into the cxTi10882 IV site.52
Insertion sites and integrity of the integrated sequences were verified by PCR and
restriction mapping.

RT-qPCR. The detailed protocol has been described previously.19 Total RNA was
extracted from worms or primary neurons with TRIzol LS reagent (Life Technologies,
Carlsbad, CA, USA; no. 10296-010). Primers for m-nonN-Nmnat1 (all nonN-Nmnat1
constructs were mCherry and 6 × his tagged): forward, 5′-ACTGGAAAAGCCT
GGGGCGGCGGCGGC-3′ and reverse, 5′-ATGGTGATGGTGATGCAAAGTGGA
ATGG-3′; β-actin: forward, 5′-GACATGGAGAAGATCTGGCA-3′ and reverse, 5′-GGT
CTCAAACATGATCTGGGT-3′; hspa9: forward, 5′-CAGGAAGAAGGAACGTGTTG-3′
and reverse, 5′-GCTTGTTGCACTCATCAGCAG-3′; hspd1: forward, 5′-CCTGTG
ACAACCCCTGAAG-3′ and reverse, 5′-CACTCAACAAGACATAGGCA-3′. qPCR
(SYBR green) was run at 95 °C for 15 s and 60 °C for 30 s and analyzed using
the ΔΔCT method.

C. elegans hypoxia assays. Hypoxic incubation and scoring of C. elegans
was performed as described previously.18 For each trial, three plates of young adult
worms (one day after L4 worms, 30–60 worms per plate) were used. After hypoxic

Hippocampal neurons and hypoxic treatment. Primary P0 mouse
hippocampal neurons were established in poly-D-lysine-coated 4-well dishes with
Neurobasal medium supplemented with B27 (Life Technologies; 17504-044),
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L-glutamine and FUDR to prevent glial growth. After 5 days in vitro, the neurons
were infected with lentivirus containing sequence encoding the desired proteins.24
Five days after infection, nonN-Nmnat1 expression was confirmed by checking for
the coexpressing GFP signal. Cultures were either harvested for RNA extraction or
treated with hypoxia (o0.3% O2) for 7 h at 37 °C, followed by overnight recovery
under normal culture condition. To score for cell death, cultures were stained by
ethidium homodimer (Life Technologies; E1169) before fixation. Cells were then
stained with Tuj1 (Abcam, Cambridge, UK, AB14545) antibody to identify neurons
(green signal shown in Supplementary Figure S1) and with DAPI to identify all cells.
At least 10 high-power fields were taken for each infection, and survival values from
these fields were pooled as one trial.

Statistical analysis. GraphPad Prism 6 software (La Jolla, CA, USA) was
used for all statistical analysis. Statistical significance was determined by tests
indicated in individual figure legends. Paired T-tests were used when all trials had
concurrent controls; unpaired T-tests were used for all other experiments except
lifespan comparisons where log-rank tests were performed.
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